Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters










Database
Language
Publication year range
1.
Dtsch Med Wochenschr ; 135(12): 557-62, 2010 Mar.
Article in German | MEDLINE | ID: mdl-20209426

ABSTRACT

INTRODUCTION: Guajac based fecal occult blood tests have proven to reduce mortality of colorectal cancer - despite their unsatisfactory statistical values. The potential of newer tests is yet inconclusive. We compared two guajac based, four immunochemical and the M2-PK test with colonoscopic and histological results as a reference. METHODS: In 1128 stool samples of patients undergoing (screening) colonoscopy the mentioned tests were performed. RESULTS: Positivity rate was 1.9 to 4.1 % for guajac based and immunochemical tests, M2-PK reached 11.6 %. In case of advanced neoplasias, no significant differences in sensitivity (7.3 - 20 %), specifity (96.6 - 98.4 %), positive predictive value (16.7 - 30.6 %) or accuracy (92.9 - 94.0 %) between guajac based and immunochemical tests were encountered. The slightly higher sensitivity of M2-PK (27.3 %) did not reach statistical significance - however the comparatively low specifity (89.2 %) and accuracy (86.2 %) were clearly lower compared to all other tests. Regarding all neoplasia, immunochemical tests performed better than conventional hemoccult, but the difference did not reach statistical significance. In this group, the sensitivity of M2-PK is clearly better, but specifity is clearly inferior to all other tests. DISCUSSION: Low sensitivity and low predictive values are explained by the study design with single test and low prevalence of neoplasia. Due to small numbers, there is only a trend, but no significant difference between the performance of conventional hemoccult compared with immunochemical and high senstitive guajac tests. Because of its low specificity, M2-PK is not an appropriate screening test for colorectal neoplasia.


Subject(s)
Colonoscopy/methods , Colorectal Neoplasms/diagnosis , Mass Screening/methods , Occult Blood , Data Interpretation, Statistical , Humans , Reproducibility of Results , Sensitivity and Specificity
2.
Dtsch Med Wochenschr ; 131(8): 379-83, 2006 Feb 24.
Article in German | MEDLINE | ID: mdl-16479468

ABSTRACT

BACKGROUND AND OBJECTIVE: In October 2002 screening coloscopy was introduced into the National Cancer Prevention Programme in Germany. The results of an online registry are presented here. METHODS: Data from consecutive screening colonoscopies in the practices of the 280 participating gastroenterologists, performed in asymptomatic subjects, were collected in an online registry. Number and histology of colorectal polyps and carcinomas, complication rates of colonoscopy and polypectomy were registered. Advanced adenoma was defined as an adenoma >10 mm in diameter, with villous or tubulovillous histology, or presence of high-grade dysplasia. RESULTS: A total of 109989 colonoscopies (43% in males) were evaluated from October 2003 to July 2005. Tubular and villous adenomas were found in 16.2% and 3.8%, respectively, whereas invasive cancers were diagnosed in 0.7%. Advanced adenomas amounted to 6.1%.The majority of carcinomas were detected in early stages (UICC stages I and II in 48 and 22 %, respectively). -In most of the polyps immediate polypectomy was carried out. The complication rate was low and no deaths were observed: cardiopulmonary complications occurred in 0.10% of the colonoscopies, bleeding in 0.79% of polypectomies most of which were managed endoscopically (surgery in 0.04% of polypectomies). Perforation occurred in 0.02% of the colonoscopies and 0.10% of polypectomies. CONCLUSIONS: Neoplasias of the colon were detected in about 20% of persons who had taken part in a colonoscopy screening programme: most of the lesions were immediately removed by polypectomy. The high rate of early stages of colorectal cancers detected by screening colonoscopy is an indirect indicator of mortality reduction. In Germany screening colonoscopy has a low risk.


Subject(s)
Adenoma, Villous/epidemiology , Adenoma/epidemiology , Carcinoma/epidemiology , Colonic Neoplasms/epidemiology , Colonic Polyps/epidemiology , Colonoscopy , Colorectal Neoplasms/epidemiology , Internet , Mass Screening , Registries , Adenoma/pathology , Adenoma, Villous/pathology , Age Factors , Aged , Aged, 80 and over , Carcinoma/pathology , Colon/pathology , Colonic Neoplasms/pathology , Colonic Polyps/pathology , Colonic Polyps/surgery , Colonoscopy/adverse effects , Colorectal Neoplasms/pathology , Endoscopy , Female , Germany/epidemiology , Humans , Male , Middle Aged , Neoplasm Staging , Prevalence , Sex Factors
3.
Dtsch Med Wochenschr ; 115(21): 809-12, 1990 May 25.
Article in German | MEDLINE | ID: mdl-2187669

ABSTRACT

The sensitivity and specificity of ultrasound-directed fine-needle biopsy in the differentiation of malignancy or otherwise of structures in the abdomen or retroperitoneal space which look suspicious on ultrasound was evaluated from results in 558 patients (306 men, 252 women). Data from two different centres were used to characterize further the influence of different techniques of puncture, cytopathologists and groups of patients on the validity of the examination. Sensitivity (in the two centres) was 88 and 80%, respectively, specificity 100 and 99%. The validity of the examination was the same at both centres. In both centres the sensitivity was worst for pancreatic tissue, at only 72 and 61% respectively, compared with other organs (e.g. liver, lymph nodes, kidney) (P less than 0.05). Fine-needle biopsy of abdominal and retroperitoneal organs will thus be subject to a not insignificant number of false-negative results of cytological examination.


Subject(s)
Abdomen/pathology , Biopsy, Needle/methods , Ultrasonography/methods , Biopsy, Needle/instrumentation , Cytodiagnosis/instrumentation , Cytodiagnosis/methods , False Negative Reactions , Humans , Reproducibility of Results , Retroperitoneal Space
SELECTION OF CITATIONS
SEARCH DETAIL
...